Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings

Two important studies evaluating the safety profile of oral estrogen-progestogen hormonal therapies conducted in standard clinical practice with respect to the venous system were recently published. A large prospective controlled cohort study (PRO-E2) based on the non-inferiority design has shown th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bińkowska, Małgorzata, Jakimiuk, Artur, Paszkowski, Tomasz, Pawelczyk, Leszek, Skrzypulec-Plinta, Violetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551365/
https://www.ncbi.nlm.nih.gov/pubmed/36254131
http://dx.doi.org/10.5114/pm.2022.119861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551365/
https://www.ncbi.nlm.nih.gov/pubmed/36254131
http://dx.doi.org/10.5114/pm.2022.119861

Ejemplares similares